ABUS vs CINF · P/E 5.4, rev $6.2M vs P/E 16, rev $11.34B
Arbutus Biopharma Corp (ABUS) versus Cincinnati Financial Corporation (CINF) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Not investment advice. Open the ABUS and CINF stock pages for the full models.
Not investment advice.